When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 10 Hits
  • Search Condition : Filter (MeSH = Thiourea / pharmacology)
Species Resource Title
Human and Animal Cells NUGC-4(RCB1939) The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.
Human and Animal Cells A549(RCB0098) Radiation quality effects alteration in COX-2 pathway to trigger radiation-induced bystander response in A549 lung carcinoma cells.
C.elegans tm1689 Rescue of ATXN3 neuronal toxicity in Caenorhabditiselegans by chemical modification of endoplasmic reticulum stress.
Prokaryotes E. coli ME9796 , ME9797 , ME9798 , ME9799 , ME9800 , ME9801 , ME9802 , ME9803 , ME9804 , ME9805 Exclusion of assembled MreB by anionic phospholipids at cell poles confers cell polarity for bidirectional growth.
DNA material pCIneoFLAG-LATS1 (RDB14396) , pCIneoFHF-PP1A (RDB14397) , pCIneoFHF-PP2A (RDB14398) , pCIneoLuc-TAZ (RDB14399) , pCIneoFH-TAZ (RDB14400) , pCIneoEGFPC2 (RDB14401) , pLL3.7-FLAG-YAP1 (RDB14395) Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Human and Animal Cells Anti-infectious effect of S-benzylisothiourea compound A22, which inhibits the actin-like protein, MreB, in Shigella flexneri.
Human and Animal Cells THP-1(RCB1189) ERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cells.
Human and Animal Cells CACO-2(RCB0988) Human neutrophil peptides induce interleukin-8 in intestinal epithelial cells through the P2 receptor and ERK1/2 signaling pathways.
Prokaryotes E. coli JW0106-KC(ampD) Growth of Escherichia coli: significance of peptidoglycan degradation during elongation and septation.
General Microbes JCM 5705 , JCM 5885 , JCM 5890 Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q.